The cell therapy developer, which raised nearly $500 million in 2023 on the promise of its CAR-T work, has floundered since a ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

Malaria, which is typically passed on by mosquitoes but can also be transmitted via blood transfusion and contaminated needles, can be life-threatening. Pregnant women, travelers and infants are at ...

The complaint argues Kennedy’s actions to remove the COVID vaccine from the CDC's immunization schedule for pregnant people ...

Acadia Pharmaceuticals has proposed that its pipeline of experimental medicines could, if eventually brought to market, peak at $12 billion in annual sales. The brain drug developer disclosed this ...

Dive Brief: Vor Biopharma is licensing rights to an immune disease drug from Chinese biotechnology company RemeGen, it said Wednesday, a little over one month after announcing plans to review ...

Robert F. Kennedy Jr.’s newly hand-picked panel of federal vaccine advisers met for the first time Wednesday since the Health and Human Services secretary abruptly fired their predecessors earlier ...

Dive Brief: Amgen’s experimental obesity drug MariTide helped people with obesity lose an average of up to 16% of their body weight over the course of a year, according to full data from a Phase 2 ...

Dive Brief: Perceptive Xontogeny Venture Funds and venBio Partners are contributing up to $40 million to a spinout of genetic medicine maker Lexeo Therapeutics to that will aim to advance drugs for ...

Today, a brief rundown of news involving Sarepta Therapeutics, Capricor Therapeutics and Nektar Therapeutics, as well as updates from AstraZeneca, Revolution Medicines and Carisma Therapeutics that ...

Senator Bill Cassidy, a powerful Republican senator from Louisiana, has called for an important federal vaccine meeting this week to be delayed, after Health and Human Services Secretary Robert F.

Dive Brief: Shares of San Diego biotechnology company Cidara Therapeutics doubled Monday after the company revealed positive mid-stage study results for an experimental preventive therapy it’s ...